Citation: Jh. Jansson et al., VON-WILLEBRAND-FACTOR, TISSUE-PLASMINOGEN ACTIVATOR, AND DEHYDROEPIANDROSTERONE-SULFATE PREDICT CARDIOVASCULAR DEATH IN A 10-YEAR FOLLOW-UPOF SURVIVORS OF ACUTE MYOCARDIAL-INFARCTION, HEART, 80(4), 1998, pp. 334-337
Authors:
KRISTENSEN B
MALM J
NILSSON TK
HULTDIN J
CARLBERG B
OLSSON T
Citation: B. Kristensen et al., INCREASED FIBRINOGEN LEVELS AND ACQUIRED HYPOFIBRINOLYSIS IN YOUNG-ADULTS WITH ISCHEMIC STROKE, Stroke, 29(11), 1998, pp. 2261-2267
Authors:
LINDAHL B
NILSSON TK
ASPLUND K
HALLMANS G
Citation: B. Lindahl et al., INTENSE NONPHARMACOLOGICAL INTERVENTION IN SUBJECTS WITH MULTIPLE CARDIOVASCULAR RISK-FACTORS - DECREASED FASTING INSULIN LEVELS BUT ONLY AMINOR EFFECT ON PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY, Metabolism, clinical and experimental, 47(4), 1998, pp. 384-390
Authors:
THOGERSEN AM
JANSSON JH
BOMAN K
NILSSON TK
WEINEHALL L
HUHTASAARI F
HALLMANS G
Citation: Am. Thogersen et al., HIGH PLASMINOGEN-ACTIVATOR INHIBITOR AND TISSUE-PLASMINOGEN ACTIVATORLEVELS IN PLASMA PRECEDE A FIRST ACUTE MYOCARDIAL-INFARCTION IN BOTH MEN AND WOMEN - EVIDENCE FOR THE FIBRINOLYTIC SYSTEM AS AN INDEPENDENTPRIMARY RISK FACTOR, Circulation, 98(21), 1998, pp. 2241-2247
Citation: K. Boman et al., IMPROVED FIBRINOLYSIS AFTER ONE-YEAR OF TREATMENT WITH ENALAPRIL IN MEN AND WOMEN WITH MYOCARDIAL-INFARCTION - A POSSIBLE MECHANISM OF PROGNOSTIC IMPORTANCE, Circulation, 98(17), 1998, pp. 2761-2761
Authors:
NILSSON JB
NILSSON TK
JANSSON JH
BOMAN K
THOGERSEN AM
NASLUND U
Citation: Jb. Nilsson et al., RELATIONSHIP BETWEEN FIBRINOLYTIC-ACTIVITY FOLLOWING STREPTOKINASE TREATMENT IN ACUTE MYOCARDIAL-INFARCTION AND VECTORCARDIOGRAPHIC SIGNS OF REPERFUSION, Fibrinolysis & proteolysis, 11(4), 1997, pp. 193-199
Authors:
NILSSON TK
BOMAN K
JANSSON JH
BRANNSTROM M
Citation: Tk. Nilsson et al., PREDICTION OF BLEEDING COMPLICATIONS IN PATIENTS ON ORAL ANTICOAGULANTS BY THROMBOMODULIN, Thrombosis and haemostasis, 1997, pp. 721-721
Authors:
JANSSON JH
BOMAN K
BRANNSTROM M
NILSSON TK
Citation: Jh. Jansson et al., HIGH-CONCENTRATION OF THROMBOMODULIN IN PLASMA IS ASSOCIATED WITH HEMORRHAGE - A PROSPECTIVE-STUDY IN PATIENTS RECEIVING LONG-TERM ANTICOAGULANT TREATMENT, Circulation, 96(9), 1997, pp. 2938-2943
Authors:
UDDHAMMAR A
RANTAPAADAHLQVIST S
NILSSON TK
Citation: A. Uddhammar et al., LONG-TERM FOLLOW-UP OF VON-WILLEBRAND-FACTOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN PATIENTS WITH POLYMYALGIA-RHEUMATICA, Annals of the Rheumatic Diseases, 56(11), 1997, pp. 698-699
Citation: Ae. Henriksson et al., BLEEDING-TIME AND CONCENTRATIONS OF VON-WILLEBRAND-FACTOR IN PATIENTSWITH ACUTE UPPER GASTROINTESTINAL-BLEEDING, The European journal of surgery, 162(8), 1996, pp. 627-631
Authors:
JANSSON JH
BOMAN K
BRANNSTROM M
NILSSON TK
Citation: Jh. Jansson et al., INCREASED LEVELS OF PLASMA THROMBOMODULIN ARE ASSOCIATED WITH VASCULAR AND ALL-CAUSE MORTALITY IN PATIENTS ON LONG-TERM ANTICOAGULANT TREATMENT, European heart journal, 17(10), 1996, pp. 1503-1505
Authors:
HENRIKSSON AE
NILSSON TK
JANSSON U
BERGQVIST D
Citation: Ae. Henriksson et al., EXPERIMENTAL HEMORRHAGE AND BLOOD COMPONENT TRANSFUSION IN HUMANS - NO CHANGE IN PLASMA-CONCENTRATION OF THROMBIN-ANTITHROMBIN COMPLEX AND PLASMIN-ANTIPLASMIN COMPLEX, Thrombosis research, 82(5), 1996, pp. 409-415
Authors:
NILSSON TK
THOGERSEN AM
JANSSON JH
BOMAN K
Citation: Tk. Nilsson et al., COMPARISON OF VON-WILLEBRAND-FACTOR AND TISSUE-PLASMINOGEN ACTIVATOR CONCENTRATIONS IN PLASMA AND SERUM, Clinical chemistry, 42(6), 1996, pp. 976-977
Citation: Tk. Nilsson et K. Boman, VON-WILLEBRAND-FACTOR AND ATHEROSCLEROSIS - REPLY - ONCE MORE ON THE LACK OF ASSOCIATIONS BETWEEN VWF LEVELS AND VARIABLES OF THE INSULIN-RESISTANCE SYNDROME, Journal of internal medicine, 237(4), 1995, pp. 433-434
Authors:
LITHNER F
BERGENHEIM T
BORSSEN B
DAHLEN G
NILSSON TK
Citation: F. Lithner et al., THE ASSOCIATION OF FIBRINOLYSIS AND HYPERLIPIDEMIA WITH QUANTITATIVE SENSORY TESTS IN AN EPIDEMIOLOGIC-STUDY OF SWEDISH TYPE-1 DIABETIC-PATIENTS, Diabetic medicine, 12(7), 1995, pp. 590-594
Authors:
BRANNSTROM M
JANSSON JH
BOMAN K
NILSSON TK
Citation: M. Brannstrom et al., ENDOTHELIAL HEMOSTATIC FACTORS MAY BE ASSOCIATED WITH MORTALITY IN PATIENTS ON LONG-TERM ANTICOAGULANT TREATMENT, Thrombosis and haemostasis, 74(2), 1995, pp. 612-615
Authors:
NILSSON TK
BOMAN K
BJERLE P
HALLMANS G
HELLSTEN G
Citation: Tk. Nilsson et al., VON-WILLEBRAND-FACTOR AND FIBRINOLYTIC VARIABLES ARE DIFFERENTLY AFFECTED IN THE INSULIN-RESISTANCE SYNDROME, Journal of internal medicine, 235(5), 1994, pp. 419-423
Citation: S. Rantapaadahlqvist et Tk. Nilsson, ENDOTHELIAL-CELL DERIVED FACTORS IN RELATION TO ANTIBODIES TO SSA OR SSB AND TO ENDOTHELIAL-CELLS IN SJOGRENS-SYNDROME, Clinical rheumatology, 13(2), 1994, pp. 320-322
Citation: Ae. Henriksson et al., HYPERCOAGULABILITY IN ACUTE BLEEDING PEPTIC-ULCER DISEASE ASSESSED BYTHROMBIN-ANTITHROMBIN-III CONCENTRATIONS, The European journal of surgery, 159(3), 1993, pp. 167-169
Citation: Ae. Henriksson et al., TIME-COURSE OF CLOTTING AND FIBRINOLYTIC MARKERS IN ACUTE UPPER GASTROINTESTINAL-BLEEDING - RELATION TO DIAGNOSIS AND BLOOD-TRANSFUSION TREATMENT, Blood coagulation & fibrinolysis, 4(6), 1993, pp. 877-880